【石四药集团(02005.HK)公布多个创新药开发的最新进展】智通财经APP讯,石四药集团(02005.HK)公布,近日

智通财经
07 Jul
【石四药集团(02005.HK)公布多个创新药开发的最新进展】智通财经APP讯,石四药集团(02005.HK)公布,近日,SYN045片50mg 和100mg 的单次给药以及25mg 的多次给药临床试验已经完成。研究结果显示,人体药代动力学特征良好,安全性和耐受性较同靶点类药物显著提升,有利于实现口服长期给药。截至目前,SYN045项目已提交发明专利合计 18 件,其中国际发明专利 5 件(已提交国际 PCT 申请);国内发明专利 13 件(当中化合物、晶型、制剂等相关 5 件发明专利已获授权)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10